Skip to content
Screener

Iovance Biotherapeutics, Inc. IOVA Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$67.5MMiss by $14.7M
EPS-$0.25Beat by $0.04
Revenue estimate$82.2M
EPS estimate-$0.29

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$110.1M
EPS estimate-$0.12

Financials

Q3 2025

Income statement

See full
Revenue$67.5M+15.2%
Gross profit$29.0M+7.2%
Operating income-$94.9M-6.6%
Net income-$91.3M-9.2%

Balance sheet

See full
Cash & equivalents$158.1M-7.3%
Total debt$51.5M-34.8%
Total equity$702.3M-9.2%
Total assets$904.9M-8.7%

Cash flow

See full
Operating cash flow-$78.7M-33.5%
CapEx$10.8M+374%
Free cash flow-$89.5M-46.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$785.22M-70.6%
Enterprise value$678.58M-73.7%
P/S3.1×-26.3×

Profitability

See full
Gross margin33%+4.3pp
Operating margin-166.3%-65.4pp
Net margin-158.8%-62.4pp
FCF margin-140.5%-55.8pp

Returns & leverage

See full
Return on equity-53.9%-2.5pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.8×

Segments

By product

See full
Amtagvi$57.5M+36.7%
Proleukin$10.0M-39.6%

By segment

See full
Single Reportable$67.5M+15.2%

FAQ

When did Iovance Biotherapeutics, Inc. report Q3 2025 earnings?
Iovance Biotherapeutics, Inc. (IOVA) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Iovance Biotherapeutics, Inc.'s Q3 2025 revenue and EPS?
Iovance Biotherapeutics, Inc. reported revenue of $67.5M and eps of $-0.25 for Q3 2025.
Did Iovance Biotherapeutics, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $82.2M by $14.7M. EPS beat the consensus estimate of $-0.29 by $0.04.
How did Iovance Biotherapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.2% from $58.6M a year earlier and eps grew 10.7% from $-0.28.
Where can I find Iovance Biotherapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-107426) and the 10-Q periodic report (0001104659-25-107470) directly on SEC EDGAR. The filing index links above go to sec.gov.